Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24M Sell
18,717,422
-117,461
-0.6% -$165K 1.24% 21
2026
Q1
$28.1M Buy
18,834,883
+1,174,900
+7% +$1.79M 1.48% 20
2025
Q4
$23.3M Buy
17,659,983
+5,060,981
+40% +$6.35M 1.17% 21
2025
Q3
$17.3M Buy
12,599,002
+5,278,828
+72% +$7.03M 1.19% 23
2025
Q2
$10.3M Buy
+7,320,174
New +$10.4M 0.95% 32

Other funds holding GERN

Eversept Partners's GERN Position: Q2 2026 in Review

Eversept Partners reduced its Geron (GERN) stake by 0.62% in Q2 2026, selling an estimated $165K and leaving 18,717,422 shares worth $24M. The position accounts for 1.24% of the portfolio, ranked #21.

Eversept Partners first reported a position in GERN in Q2 2025 and has held it in 5 quarters since. The position peaked at $28.1M in Q1 2026. 260 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • Eversept Partners held 18,717,422 shares of Geron worth $24M as of Q2 2026.
  • Eversept Partners sold 117,461 Geron shares in Q2 2026, an estimated $165K.
  • Geron made up 1.24% of Eversept Partners's portfolio in Q2 2026, its #21 holding.
  • Eversept Partners first reported a position in Geron in Q2 2025 and has held it in 5 quarters since.
  • Eversept Partners's Geron position peaked at $28.1M in Q1 2026.
  • 260 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.